From the FDA Drug Label
Seborrheic dermatitis: Ketoconazole Cream 2% should be applied to the affected area twice daily for four weeks or until clinical clearing. Uses temporarily relieves itching associated with minor skin irritations, inflammation, and rashes due to: ... seborrheic dermatitis For facial seborrheic dermatitis treatment,
- Ketoconazole Cream 2% can be applied to the affected area twice daily for four weeks or until clinical clearing 1.
- Hydrocortisone can be used to temporarily relieve itching associated with seborrheic dermatitis 2.
From the Research
Facial seborrheic dermatitis can be effectively treated with a topical non-steroidal cream containing zinc PCA, piroctone olamine, hydroxyphenyl propamidobenzoic acid, biosaccharide gum-2, and stearyl glycyrrhetinate, as shown in a recent study 3.
Treatment Options
- For mild cases, start with gentle skincare and consider over-the-counter antifungal shampoos or creams.
- For more persistent cases, prescription options include antifungal agents, topical low-potency steroids, and calcineurin inhibitors.
- Topical non-steroidal creams, such as the one mentioned above, can be an effective alternative to traditional treatments.
Key Considerations
- Seborrheic dermatitis is a chronic condition with periods of flare-ups and remission, so consistent skincare is important.
- Avoid triggers like stress and harsh skincare products, and maintain gentle cleansing with lukewarm water.
- If symptoms worsen or don't improve after 2-3 weeks of treatment, consult a dermatologist for stronger prescription options.
Evidence-Based Recommendations
- A recent study published in the Journal of Drugs in Dermatology found that a topical non-steroidal cream containing zinc PCA, piroctone olamine, hydroxyphenyl propamidobenzoic acid, biosaccharide gum-2, and stearyl glycyrrhetinate was effective in treating facial seborrheic dermatitis, with 81.8% of patients showing an excellent response and 18.1% showing a good response 3.
- Another study published in the American Journal of Clinical Dermatology found that pimecrolimus, desonide, mometasone furoate, and pimecrolimus were effective topical treatments for facial seborrheic dermatitis, with low recurrence rates and high clearance rates 4.